IV infusion tested for rapid relief of severe postpartum depression
NCT ID NCT02942004
Summary
This study tested whether a 60-hour intravenous infusion of an experimental drug called SAGE-547 could reduce severe depressive symptoms in women with postpartum depression. It involved 138 women who were within 6 months of giving birth and had severe symptoms. The main goal was to see if the drug worked better than a placebo infusion at relieving depression symptoms, measured at the end of the 60-hour treatment and again 30 days later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Chandler, Arizona, 85226, United States
-
Sage Investigational Site
Rogers, Arkansas, 72758, United States
-
Sage Investigational Site
Lemon Grove, California, 91945, United States
-
Sage Investigational Site
Orange, California, 92868, United States
-
Sage Investigational Site
Ventura, California, 93003, United States
-
Sage Investigational Site
Gainesville, Florida, 32607, United States
-
Sage Investigational Site
Miami, Florida, 33147, United States
-
Sage Investigational Site
Miramar, Florida, 33027, United States
-
Sage Investigational Site
Orlando, Florida, 32807, United States
-
Sage Investigational Site
Pensacola, Florida, 32502, United States
-
Sage Investigational Site
Pinellas Park, Florida, 33782, United States
-
Sage Investigational Site
Atlanta, Georgia, 30331, United States
-
Sage Investigational Site
Hoffman Estates, Illinois, 60169, United States
-
Sage Investigational Site
Wichita, Kansas, 67226, United States
-
Sage Investigational Site
Edgewood, Kentucky, 41017, United States
-
Sage Investigational Site
Owensboro, Kentucky, 42303, United States
-
Sage Investigational Site
Boston, Massachusetts, 02114, United States
-
Sage Investigational Site
Boston, Massachusetts, 02115, United States
-
Sage Investigational Site
Flowood, Mississippi, 39232, United States
-
Sage Investigational Site
Marlton, New Jersey, 08053, United States
-
Sage Investigational Site
Glen Oaks, New York, 11004, United States
-
Sage Investigational Site
Chapel Hill, North Carolina, 27514, United States
-
Sage Investigational Site
Charlotte, North Carolina, 28211, United States
-
Sage Investigational Site
Raleigh, North Carolina, 27612, United States
-
Sage Investigational Site
Columbus, Ohio, 43210, United States
-
Sage Investigational Site
Dayton, Ohio, 45417, United States
-
Sage Investigational Site
Philadelphia, Pennsylvania, 19104, United States
-
Sage Investigational Site
Houston, Texas, 77030, United States
-
Sage Investigational Site
Houston, Texas, 77058, United States
-
Sage Investigational Site
Richardson, Texas, 75080, United States
-
Sage Investigational Site
San Antonio, Texas, 78229, United States
-
Sage Investigational Site
Orem, Utah, 84058, United States
Conditions
Explore the condition pages connected to this study.